Der Browser den Sie verwenden ist sehr alt.

Wir können daher nicht sicherstellen, dass jede Funktion (Gestaltung, Bilder und zusätzliche Funktionen) dieser Internetseite im vollen Umfang zur Verfügung steht. Bitte nutzen Sie eine aktuellere Browserversion.
Wir bitten um Ihr Verständnis.
Startseite > Forschung > Publikationen > 2004

Publikationen 2004

Egberts F, Heinrich M, Jensen JM, Winoto-Morbach S, Pfeiffer S, Wickel M, Schunck M, Steude J, Saftig P, Proksch E, Schütze S.
Cathepsin D is involved in the regulation of transglutaminase 1 and epidermal differentiation.
J Cell Sci 117: 2295-2307, 2004

Falk M, Ussat S, Reiling N, Wesch D, Kabelitz D, Adam-Klages S.
Caspase inhibition blocks human T cell proliferation by suppressing appropriate regulation of IL-2, CD25, and cell cycle-associated proteins.
J Immunol 173: 5077-5085, 2004

Göggel R, Winoto-Morbach S, Vielhaber G, Imai Y, Lindner K, Brade L, Brade H, Ehlers S, Slutsky AS, Schütze S, Gulbins E, Uhlig S.
PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide.
Nat Med 10: 155 - 160, 2004

Hampe J, Valentonyte R, Manaster C, Teuber M, Jenisch S, Entz P, Nagy M, Schreiber S.
Nonelectrophoretic method for high-throughput HLA-DRB1 group genotyping.
BioTechniques 36: 148-151, 2004

Heinrich M, Neumeyer J, Jacob M, Hallas C, Tchikov V, Winoto-Morbach S, Wickel M, Schneider-Brachert W, Trauzold A, Hethke A, Schütze S.
Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 und -3 activation.
Cell Death Differ 11: 550-563, 2004

Jensen JM, Folster-Holst R, Baranowskiy A, Schunk M, Winoto-Morbach S, Neumann C, Schütze S, Proksch E.
Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis.
J Invest Dermatol 122: 1423-31, 2004

Kabelitz D.
Hard time for anergic cytotoxic T-cells.
Blood 103: 3-4, 2004

Kabelitz D.
Disturbance of the T-cell receptor repertoire in HIV infection.
In: Immunotreatment and gene therapy of HIV infection. Hengge UR, Kabelitz, D (edts). pp. 14-24 Uni-Med Bremen, 2004

Kabelitz D, Wesch D, Pitters E, Zöller M.
Potential of human gamma/delta T lymphocytes for immunotherapy of cancer.
Int J Cancer, 112: 727-732, 2004

Kabelitz D, Pitters E, Wesch D, Zöller M.
Characterization of tumor reactivity of human Vgamma9/Vdelta2 gamma/delta T-cells in vitro and in severe combined immunodeficiency mice in vivo.
J Immunol, 173: 6767-6776, 2004

Kreuz S, Siegmund D, Rumpf JJ, Samel D, Leverkus M, Janssen O, Hacker G, Dittrich-Breiholz O, Kracht M, Scheurich P, Wajant H.
NFkB activation by Fas is mediated through FADD, Caspase-8 and RIP and is inhibited by FLIP.
J Cell Biol 166: 369 -380, 2004

Kunzendorf U, Ziegler E, Kabelitz D.
FTY720 - the first compound of a new promising class of immunosuppressive drugs.
Nephrol Dial Transplant 19: 1677-1681, 2004

Lamprecht P, Moosig F, Adam-Klages S, Mrowietz U, Csernok E, Kirrstetter M, Ahmadi-
Simab K, Schroder JO, Gross WL.
Small vessel vasculitis and relapsing panniculitis in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
Ann Rheum Dis , 63, 1518-1520, 2004

Lettau M, Qian J, Kabelitz D, Janssen O.
Activation-dependent FasL expression in T lymphocytes and Natural Killer cells.
Signal Transd 5-6:206-211, 2004

Lüschen, S , Scherer, G , Ussat, S , Ungefroren, H , Adam-Klages, S.
Inhibition of p38 mitogen-activated protein kinase reduces TNF-induced activation of NF-kB, elicits caspase activity, and enhances cytotoxicity.
Exp Cell Res 293: 196-206, 2004

Mohamed SA, Wesch D, Blumenthal A, Bruse P, Windler K, Ernst M, Kabelitz D, Oehmichen M, Meissner C.
Detection of 4977 bp deletion of mitochondrial DNA in different human blood cells.
Exp Gerontol 39: 181-188, 2004

Oberg HH, Sipos B, Kalthoff H, Janssen O, Kabelitz D.
Regulation of T-cell death associated 51 (TDAG51) in human T-cells.
Cell Death Differ 11: 674-684, 2004

Schneider-Brachert W, Tchikov V, Neumeyer J, Jakob M, Winoto-Morbach S, Held-Feindt J, Heinrich M, Merkel O, Ehrenschwender M, Adam D, Mentlein R, Kabelitz D, Schütze S.
Compartmentaliziation of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles.
Immunity 21: 415-428, 2004

Siegel S, Steinmann J, Schmitz N, Stuhlmann R, Dreger, P, Zeis M.
Identification of a surviving-derived peptide that induces HLA-A*0201-restricted antileukemia cytotoxic T lymphocytes.
Leukemia 18: 2046-2047, 2004

Subklewe M, Nagy M, Schoch C, Jenisch S, Siebert R, Gesk S, Neuhaus P, Dörken B, Schmidt CA .
Extramedullary manifestation of a donor-derived acute myeloid leukemia in a liver transplant patient.
Leukemia 18: 2050-2053, 2004

Weise, JB, Maune, S, Görögh T, Kabelitz D, Arnold N, Pfisterer, J, Hilpert F, Heiser, A.
A dendritic cell based hybrid cell vaccine generated by electrofusion for immunotherapy strategies in HNSCC.
Auris Nasus Larynx 31: 149-153, 2004

Weise JB, Hilpert F, Heiser A, Görögh T, Meyer JE, Weimer J, Krüger C, Rosenau A, Wieckhorst W, Arnold N, Pfisterer J, Kabelitz D, Maune S.
Electrofusion generates diverse DC-tumour cell hybrids for cancer immunotherapy.
Anticancer Res 24: 929-934, 2004